Central serous chorioretinopathy (CSC) is a common cause of central vision loss, primarily
affecting men 20–60 years of age. To date, no consensus has been reached regarding the …

Macular edema consists of intra-or subretinal fluid accumulation in the macular region. It
occurs during the course of numerous retinal disorders and can cause severe impairment of …

Genomic profiling shows that many solid tumors are characterized by specific driver
aberrations, and this has expanded the therapeutic options for many patients. The mitogen …

Background The combined inhibition of BRAF and MEK is hypothesized to improve clinical
outcomes in patients with melanoma by preventing or delaying the onset of resistance …

Central serous chorioretinopathy (CSCR) is a major cause of vision threat among middle-
aged male individuals. Multimodal imaging led to the description of a wide range of CSCR …

Central serous chorioretinopathy (CSC) is a common form of vision loss, typically seen in
working-age men. The pathophysiology behind CSC still eludes us, however significant …

The inhibition of the mitogen-activated protein kinases signalling pathway through combined
use of BRAF and MEK inhibitors (BRAFi+ MEKi) represents an established therapeutic …

The term “immunogenic cell death”(ICD) is now employed to indicate a functionally peculiar
form of apoptosis that is sufficient for immunocompetent hosts to mount an adaptive immune …

Central serous chorioretinopathy (CSC) is a relatively common disease that causes vision
loss due to macular subretinal fluid leakage and is often associated with reduced vision …

A wide range of ocular diseases can present with serous subretinal fluid in the macula and
therefore clinically mimic central serous chorioretinopathy (CSC). In this manuscript, we …